Acoustically Mediated Controlled Drug Release and Targeted Therapy with Degradable 3D Porous Magnetic Microrobots.
Jongeon ParkJin-Young KimSalvador PanéBradley J NelsonHong Soo ChoiPublished in: Advanced healthcare materials (2020)
Microrobots for targeted drug delivery are of great interest due to their minimal invasiveness and wireless controllability. Here, a magnetically driven porous degradable microrobot (PDM) is reported that consists of a 3D printed helical soft polymeric chassis made of a poly(ethylene glycol) diacrylate and pentaerythritol triacrylate matrix containing magnetite nanoparticles and the anticancer drug 5-fluorouracil (5-FU). The encapsulated Fe3 O4 nanoparticles render the PDM a precise wireless magnetic actuation by means of rotating magnetic fields (RMFs). The increased surface area of the porous PDM facilitates the acoustically induced drug release due to a higher response to the acoustic energy. The drug release profile from the PDM can be selected on command from three different modes, referred to herein as natural, burst, and constant, by differentiating the ultrasound exposure condition. Finally, in vitro test results reveal different therapeutic results for each release mode. The observed great reduction of cancer cell viability in the burst- and constant-release modes confirms that ultrasound with the proposed PDM can enhance the therapeutic effect by increasing drug concentration and sonoporation.
Keyphrases
- drug release
- drug delivery
- cancer therapy
- molecularly imprinted
- magnetic resonance imaging
- metal organic framework
- drug induced
- high frequency
- papillary thyroid
- highly efficient
- high glucose
- single cell
- magnetic resonance
- ultrasound guided
- diabetic rats
- adverse drug
- young adults
- mass spectrometry
- oxidative stress
- squamous cell
- high resolution
- lymph node metastasis
- contrast enhanced ultrasound
- liquid chromatography
- tandem mass spectrometry